Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. more
Time Frame | DXCM | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.05% | 1.76% | -2.5% |
1-Month Return | 3.43% | 0.33% | -3.91% |
3-Month Return | 15.41% | -8.58% | -0.59% |
6-Month Return | -29.35% | -4.26% | 3.45% |
1-Year Return | -35.85% | 1.27% | 22.31% |
3-Year Return | -29.93% | 5.33% | 25% |
5-Year Return | 35.41% | 38.09% | 77.23% |
10-Year Return | 432.36% | 102.29% | 188.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.48B | 1.93B | 2.45B | 2.91B | 3.62B | [{"date":"2019-12-31","value":40.75,"profit":true},{"date":"2020-12-31","value":53.19,"profit":true},{"date":"2021-12-31","value":67.6,"profit":true},{"date":"2022-12-31","value":80.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 544.50M | 646.60M | 768.00M | 1.03B | 1.33B | [{"date":"2019-12-31","value":40.84,"profit":true},{"date":"2020-12-31","value":48.49,"profit":true},{"date":"2021-12-31","value":57.6,"profit":true},{"date":"2022-12-31","value":77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 931.50M | 1.28B | 1.68B | 1.88B | 2.29B | [{"date":"2019-12-31","value":40.7,"profit":true},{"date":"2020-12-31","value":55.93,"profit":true},{"date":"2021-12-31","value":73.42,"profit":true},{"date":"2022-12-31","value":82.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 63.11% | 66.44% | 68.63% | 64.72% | 63.19% | [{"date":"2019-12-31","value":91.95,"profit":true},{"date":"2020-12-31","value":96.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.29,"profit":true},{"date":"2023-12-31","value":92.07,"profit":true}] |
Operating Expenses | 789.20M | 980.60M | 1.41B | 1.49B | 1.69B | [{"date":"2019-12-31","value":46.67,"profit":true},{"date":"2020-12-31","value":57.98,"profit":true},{"date":"2021-12-31","value":83.65,"profit":true},{"date":"2022-12-31","value":88.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 142.30M | 299.50M | 175.40M | 391.20M | 597.70M | [{"date":"2019-12-31","value":23.81,"profit":true},{"date":"2020-12-31","value":50.11,"profit":true},{"date":"2021-12-31","value":29.35,"profit":true},{"date":"2022-12-31","value":65.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (72.00M) | (143.10M) | (109.30M) | (19.00M) | 227.40M | [{"date":"2019-12-31","value":-31.66,"profit":false},{"date":"2020-12-31","value":-62.93,"profit":false},{"date":"2021-12-31","value":-48.07,"profit":false},{"date":"2022-12-31","value":-8.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 104.20M | 225.00M | 173.90M | 390.80M | 710.40M | [{"date":"2019-12-31","value":14.67,"profit":true},{"date":"2020-12-31","value":31.67,"profit":true},{"date":"2021-12-31","value":24.48,"profit":true},{"date":"2022-12-31","value":55.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 3.10M | (268.60M) | 19.20M | 49.60M | 168.90M | [{"date":"2019-12-31","value":1.84,"profit":true},{"date":"2020-12-31","value":-159.03,"profit":false},{"date":"2021-12-31","value":11.37,"profit":true},{"date":"2022-12-31","value":29.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 101.10M | 493.60M | 154.70M | 341.20M | 541.50M | [{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":91.15,"profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":63.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 101.10M | 493.60M | 154.70M | 341.20M | 541.50M | [{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":91.15,"profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":63.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 101.10M | 493.60M | 154.70M | 341.20M | 541.50M | [{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":91.15,"profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":63.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 0.46 | 0.78 | 0.66 | 0.87 | 1.51 | [{"date":"2019-12-31","value":30.46,"profit":true},{"date":"2020-12-31","value":51.66,"profit":true},{"date":"2021-12-31","value":43.71,"profit":true},{"date":"2022-12-31","value":57.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
DXCM | |
---|---|
Cash Ratio | 1.44 |
Current Ratio | 2.46 |
Quick Ratio | 2.12 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DXCM | |
---|---|
ROA (LTM) | 6.06% |
ROE (LTM) | 32.06% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DXCM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.69 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.31 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DXCM | |
---|---|
Trailing PE | 48.60 |
Forward PE | 39.06 |
P/S (TTM) | 7.91 |
P/B | 15.81 |
Price/FCF | 354 |
EV/R | 7.94 |
EV/Ebitda | 32.18 |
PEG | 1.25 |
DexCom Inc (DXCM) share price today is $79.84
Yes, Indians can buy shares of DexCom Inc (DXCM) on Vested. To buy DexCom Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DXCM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of DexCom Inc (DXCM) via the Vested app. You can start investing in DexCom Inc (DXCM) with a minimum investment of $1.
You can invest in shares of DexCom Inc (DXCM) via Vested in three simple steps:
The 52-week high price of DexCom Inc (DXCM) is $142. The 52-week low price of DexCom Inc (DXCM) is $62.34.
The price-to-earnings (P/E) ratio of DexCom Inc (DXCM) is 48.6
The price-to-book (P/B) ratio of DexCom Inc (DXCM) is 15.81
The dividend yield of DexCom Inc (DXCM) is 0.00%
The market capitalization of DexCom Inc (DXCM) is $31.99B
The stock symbol (or ticker) of DexCom Inc is DXCM